China's top court to revisit alleged 'hub-and-spoke' API scheme
China’s Supreme People’s Court on Friday will hear a closely watched antitrust case involving an alleged “hub-and-spoke” arrangement in the country’s market for the active pharmaceutical ingredient ornidazole. China’s Supreme People’s Court...To view the full article, register now.
Already a subscriber? Click here to view full article